Fri, Aug 1, 2014, 10:09 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Cytosorbents Corporation Message Board

saltheartrules 8 posts  |  Last Activity: Jul 9, 2014 8:38 AM Member since: Jun 28, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • saltheartrules by saltheartrules Jul 9, 2014 8:38 AM Flag

    Judge Upholds Prior Decision That State Regulations Cannot Usurp Federal Law

    SAN DIEGO, Jul 09, 2014 (GLOBE NEWSWIRE via COMTEX) --

    Zogenix, Inc. ZGNX +1.08% today commented on the order issued by the U.S. District Court in Massachusetts upholding its prior decision that imposing regulations to restrict access to Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, CII, violates Constitutional law.

  • saltheartrules saltheartrules Jun 8, 2014 6:18 PM Flag

    I never pegged you as Lowenstein (aschoff) but an MM definitely.. Like Lowey though you can be disingenuous with overly critical opinions here.. No doubt trying to influence people one way or the other to suit your needs of the day...

  • saltheartrules saltheartrules Jun 7, 2014 11:18 PM Flag

    Analyst Jonathan Aschoff quote after getting caught impersonating a doctor to derive clinical data from an ongoing trial..
    "I'm trying to bring the truth to investors." He acknowledges lying about being a doctor but says it was "for the greater good of unearthing the truth."
    ...and now Dr. Lowenstiein's motto on his personal home page at Investorhub

    "working 24/7 for truth and honesty..."

    The guy is indeed a marketmaker and is known as an analyst that will change his coverage from a buy to a sell without any public information disseminated... He did it with Celsion and with Dendreon... He shorted just before clinical data was made public and made his cronies loads of cash...

  • saltheartrules saltheartrules Jun 7, 2014 5:19 PM Flag

    A recent study in Canada states that the median length of stay for severe sepsis patients was 20 days..

  • saltheartrules saltheartrules Jun 4, 2014 7:49 AM Flag

    I don't know about BMA but Lowenstein (Aka jonathan aschoff) woks for Brean murray as an analyst... I posted this a year ago when I tracked his yahoo posts to 4 stocks. These 4 stocks were the 4 most recent stocks that this analyst covered..
    Then Lowey disappeared as soon as he initiated coverage on ctso...
    He was busted 10 years ago by the sec for posing as a real doctor, (Dr. Rosen) to derive information about an ongoing trial. When asked why he chose Dr. Rosen as his fake name he said it was Chevy Chases fake Dr, name in the movie Fletch...
    Dr. Lowenstien (who claimed to be female)is also from a movie as it is Barbara Striesand's character from the Prince of tides..

  • Reply to

    How To "Power" a Trial

    by z3peru May 26, 2014 1:36 PM
    saltheartrules saltheartrules May 26, 2014 4:12 PM Flag

    Another way for ctso to power their trial is to let the post hoc data from the german trial to inform the protocols for the fda trial.
    In short I would include IL6 levels at 8000 or higher for enrollment..(Added to the standtard criteria from the German trial defining severe sepsis)
    IL6 has always been THE cytokine corrolated with inflammation and these patients(post hoc) had a statistically significant mortality benefit.. Statistically it would take far fewer patients to show a mortality benefit in this refined target population...
    The only angle they may take to power the trial is treating only those over 65 years as that population responded very well also..

  • Reply to

    BMA Post from IHUB--wud scare investors

    by invst2010 May 23, 2014 1:27 PM
    saltheartrules saltheartrules May 24, 2014 10:20 PM Flag

    They are nailing down an application in cardiac surgery. While you may opine that this is because they are failing with sepsis, I believe that it has more to do with the cost effectiveness and speed at which such a trial could be accomplished. We all know the score that ctso hasn't proven a mortality benefit in sepsis yet and they won't have to go after a mortality benefit in the cardiac indication, only healthier patients post surgery... Much easier to achieve and right up ctsosorbs alley... So why not go after the smaller cardiac market whole hog all the while selling the filter on label to those doctors that want to use it to fight inflammmation in sepsis?
    My advice to you is keep your 6.7 million shares, keep quiet, and watch this thing go mainstream with the rest of the ctso investors...

  • saltheartrules saltheartrules May 4, 2014 8:14 PM Flag

    Im with you biff.... Got 5k shares at avg. $4.05 and am holding as long as margins are good....Should be a good year with sub 5$ corn!

0.240.00(-0.41%)Aug 1 3:57 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NYSEFri, Aug 1, 2014 4:00 PM EDT
Bally Technologies, Inc.
NYSEFri, Aug 1, 2014 4:03 PM EDT
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT